Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

ZIOPHARM Oncology Inc. (ZIOP)

2.96   -0.11 (-3.58%) 05-29 16:00
Open: 3.21 Pre. Close: 3.07
High: 3.21 Low: 2.9
Volume: 2,032,117 Market Cap: 634M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.545 - 3.563 3.563 - 3.578
Low: 2.994 - 3.01 3.01 - 3.024
Close: 3.046 - 3.072 3.072 - 3.093

Technical analysis

as of: 2020-05-29 4:01:43 PM
Overall:       
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 3.67     One year: 4.15
Support: Support1: 2.48    Support2: 2.06
Resistance: Resistance1: 3.14    Resistance2: 3.55
Pivot: 2.98
Moving Average: MA(5): 3.23     MA(20): 2.90
MA(100): 3.16     MA(250): 4.24
MACD: MACD(12,26): 0.11     Signal(9): 0.09
Stochastic oscillator: %K(14,3): 62.50     %D(3): 74.89
RSI: RSI(14): 49.65
52-week: High: 7.25  Low: 1.80  Change(%): -30.1
Average Vol(K): 3-Month: 188776  10-Days: 198538

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ZIOP has closed above bottom band by 43.6%. Bollinger Bands are 2.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 27 May 2020
Ziopharm Oncology Announces Management Transition Nasdaq:ZIOP - GlobeNewswire

Fri, 29 May 2020
An in-depth look at the ZIOPHARM Oncology, Inc. (ZIOP) stock - Marketing Sentinel

Fri, 08 May 2020
Ziopharm Oncology Inc (ZIOP) Q1 2020 Earnings Call Transcript - Motley Fool

Thu, 28 May 2020
ZIOPHARM Oncology Inc (ZIOP) Plunges 12.03% on May 28 - Equities.com

Fri, 29 May 2020
Analyst’s Sets ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) New Target at $5.92: ZIOP is Now On A Buy List - State Reviewer

Fri, 29 May 2020
Ziopharm Oncology Presents Encouraging Clinical Data for Controlled IL-12 for the Treatment of Recurrent Glioblastoma at the 2020 American Society of Clinical Oncology - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 214
Shares Float (M) 191
% Held by Insiders 7.12
% Held by Institutions 48.07
Shares Short (K) 28,500
Shares Short P. Month (K) 32,160

Stock Financials

EPS -0.690
EPS Est This Year -0.560
EPS Est Next Year -0.600
Book Value (p.s.) 0.850
Profit Margin
Operating Margin
Return on Assets (ttm) -27.9
Return on Equity (ttm) -96.4
Qtrly Rev. Growth
Gross Profit (p.s.) -0.179
Sales Per Share
EBITDA (p.s.) -0.291
Qtrly Earnings Growth
Operating Cash Flow (M) -41
Levered Free Cash Flow (M) -22

Stock Valuations

PE Ratio -4.23
PEG Ratio
Price to Book value 3.44
Price to Sales
Price to Cash Flow -15.44

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.